Ashley  Dreier net worth and biography

Ashley Dreier Biography and Net Worth

Ashley Dreier serves as Independent Director of the Company. She has been the Executive Vice President and Chief Information and Technology officer of HealthEquity since 2013 where she is responsible for leading technology and ensuring strategic alignment and execution of the platform strategy across the organization. Prior to joining HealthEquity, Ms. Dreier served as Vice President Technology and Product Development at Krames StayWell from 2008 to 2013, where she was responsible for strategy and delivery of the core product offering of consumer health information and wellness platforms. Prior to joining Krames StayWell she was Director of Product Development at GE where she led the delivery of corporate payment products. Her professional background also includes Director of Software Project Management and Director of Information Systems at Wolters Kluwer and Sr. Financial Analyst at Boeing Company. Ms. Dreier holds a B.S. in accounting and an M.S. in information systems both from the University of Utah. Ms. Dreier has been a member of our board of directors since May 2018.

What is Ashley Dreier's net worth?

The estimated net worth of Ashley Dreier is at least $4.71 million as of September 2nd, 2020. Ms. Dreier owns 58,694 shares of HealthEquity stock worth more than $4,710,780 as of April 26th. This net worth approximation does not reflect any other investments that Ms. Dreier may own. Learn More about Ashley Dreier's net worth.

How do I contact Ashley Dreier?

The corporate mailing address for Ms. Dreier and other HealthEquity executives is 15 WEST SCENIC POINTE DRIVE SUITE 100, DRAPER UT, 84020. HealthEquity can also be reached via phone at (801) 727-1000 and via email at [email protected]. Learn More on Ashley Dreier's contact information.

Has Ashley Dreier been buying or selling shares of HealthEquity?

Ashley Dreier has not been actively trading shares of HealthEquity within the last three months. Most recently, Ashley Dreier sold 16,250 shares of the business's stock in a transaction on Wednesday, September 2nd. The shares were sold at an average price of $60.00, for a transaction totalling $975,000.00. Following the completion of the sale, the vice president now directly owns 58,694 shares of the company's stock, valued at $3,521,640. Learn More on Ashley Dreier's trading history.

Who are HealthEquity's active insiders?

HealthEquity's insider roster includes Edward Bloomberg (COO), Frank Corvino (Director), Adrian Dillon (Director), Ashley Dreier (VP), Angelique Hill (VP), Jon Kessler (CEO), Delano Ladd (EVP), Debra McCowan (Director), Darcy Mott (Insider), Tyson Murdock (Chief Financial Officer), William Otten (VP), Stuart Parker (Director), Ian Sacks (Director), Larry Trittschuh (EVP), and Gayle Wellborn (Director). Learn More on HealthEquity's active insiders.

Are insiders buying or selling shares of HealthEquity?

In the last twelve months, insiders at the sold shares 14 times. They sold a total of 212,813 shares worth more than $15,316,337.13. The most recent insider tranaction occured on March, 26th when Director Evelyn S Dilsaver sold 32,500 shares worth more than $2,576,925.00. Insiders at HealthEquity own 2.7% of the company. Learn More about insider trades at HealthEquity.

Information on this page was last updated on 3/26/2024.

Ashley Dreier Insider Trading History at HealthEquity

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/2/2020Sell16,250$60.00$975,000.0058,694View SEC Filing Icon  
1/24/2020Sell26,993$71.02$1,917,042.8653,737View SEC Filing Icon  
5/14/2018Sell36,000$70.94$2,553,840.0049,939View SEC Filing Icon  
5/2/2018Sell3,000$67.00$201,000.0036,189View SEC Filing Icon  
4/30/2018Sell16,250$67.00$1,088,750.0049,439View SEC Filing Icon  
3/22/2018Sell71,157$65.48$4,659,360.3621,059View SEC Filing Icon  
1/29/2018Sell12,000$52.00$624,000.0017,652View SEC Filing Icon  
12/4/2017Sell10,000$50.97$509,700.0015,652View SEC Filing Icon  
9/6/2017Sell10,000$45.50$455,000.0015,652View SEC Filing Icon  
6/5/2017Sell10,000$47.81$478,100.0015,652View SEC Filing Icon  
3/20/2017Sell5,000$45.80$229,000.005,000View SEC Filing Icon  
11/28/2016Sell5,000$43.38$216,900.005,000View SEC Filing Icon  
9/1/2016Sell10,000$32.28$322,800.0010,000View SEC Filing Icon  
12/1/2015Sell3,125$32.32$101,000.00View SEC Filing Icon  
9/3/2015Sell3,125$30.00$93,750.00View SEC Filing Icon  
6/15/2015Sell3,125$28.50$89,062.50View SEC Filing Icon  
4/28/2015Sell3,125$27.00$84,375.00View SEC Filing Icon  
See Full Table

Ashley Dreier Buying and Selling Activity at HealthEquity

This chart shows Ashley Dreier's buying and selling at HealthEquity by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

HealthEquity Company Overview

HealthEquity logo
HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is based in Draper, Utah.
Read More

Today's Range

Now: $80.26
Low: $78.40
High: $80.71

50 Day Range

MA: $81.03
Low: $78.55
High: $83.53

2 Week Range

Now: $80.26
Low: $48.86
High: $84.49

Volume

382,413 shs

Average Volume

598,253 shs

Market Capitalization

$6.89 billion

P/E Ratio

125.41

Dividend Yield

N/A

Beta

0.53